Abortion Pill Maker Sues F.D.A. to Protect Drug if a Court Orders It Off the Market
Posted inCorporations Drugs (Pharmaceuticals) Federal Courts (US) Federal-State Relations (US) Food and Drug Administration GenBioPro Inc Generic Brands and Products Mifeprex (RU-486) mifepristone Regulation and Deregulation of Industry Suits and Litigation (Civil)

Abortion Pill Maker Sues F.D.A. to Protect Drug if a Court Orders It Off the Market

The suit by GenBioPro, the generic maker of mifepristone, is the latest strand in the intense legal battle over abortion pills.
California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts
Posted inbiosimilars California CalRx Diabetes Discount Selling Drugs (Pharmaceuticals) Eli Lilly and Company Generic Brands and Products Government Contracts and Procurement Inflation Reduction Act of 2022 Insulin Law and Legislation Novo Nordisk A/S Prices (Fares, Fees and Rates) Sanofi SA

California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts

The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.